Cargando…
Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models
Cannabidiol (CBD) is a non-psychotomimetic compound present in cannabis sativa. Many recent studies have indicated that CBD has a promising therapeutic profile for stress-related psychiatric disorders, such as anxiety, schizophrenia and depression. Such a diverse profile has been associated with its...
Autores principales: | Domingos, Luana B., Silva, Nicole R., Chaves Filho, Adriano J. M., Sales, Amanda J., Starnawska, Anna, Joca, Sâmia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690868/ https://www.ncbi.nlm.nih.gov/pubmed/36421839 http://dx.doi.org/10.3390/genes13112165 |
Ejemplares similares
-
PS137. Evidence that Cannabidiol Induces Acute Antidepressant-Like Efects in Different Animal Models
por: Joca, Samia, et al.
Publicado: (2016) -
The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder
por: Mohammad, Guldar Sayed, et al.
Publicado: (2022) -
Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
por: Silote, Gabriela P., et al.
Publicado: (2021) -
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
por: Campos, Alline C., et al.
Publicado: (2017) -
The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol
por: Hartmann, Alice, et al.
Publicado: (2023)